Faeth Therapeutics FTH 深 滬
交易中 11-11 10:14:11 美东时间
14.33
+1.410
+10.91%
華盛通- 最 高14.82
- 今 開13.01
- 成交量 16.61万股
- 最 低 12.92
- 昨 收 12.92
- 總市值 3.70亿
- 52周最高 42.1431
- 市盈率 靜 --
- 換手率 0.64%
- 52周最低 7.45
- 委 比 81.82%
- 總股本 2584.39万
- 歷史最高 530.00
- 量 比 1.72
- 振 幅 14.71%
- 歷史最低 5.00
- 每 手 1
- 風險率 9.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 富国银行维持英伟达"超配"评级！但目标价从315美元降至300美元
今日重点评级关注：花旗：维持Faeth Therapeutics"买入"评级，目标价从55美元升至60美元；HC Wainwright & Co.：维持Ocular Therapeutix"买入"评级，目标价从25美元升至28美元
今天 10:50
Why Greenfire Resources Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Shares of Greenfire Resources Ltd (NYSE:GFR) rose sharply in pre-market trading after Strathcona Resources announced plans to acquire the company in a C$2.7 billion-C$2.9 billion deal, including C$550 million net debt. Greenfire Resources shares jumped 25.3% to $7.02 in pre-market trading Here are s...
11-09 17:25
美股大行评级 | 大摩上调AMD目标价至725美元；安进、多邻国绩后获华尔街大行看多
今日重点评级关注：康托·菲茨杰拉德：维持Supernus"超配"评级，目标价从67美元升至87美元；丰业银行：维持Atlas Energy Solutions"跑赢大市"评级，目标价从17美元升至18美元
11-05 14:06
Guggenheim Maintains Buy on Faeth Therapeutics, Lowers Price Target to $69
Guggenheim analyst Michael Schmidt maintains Faeth Therapeutics (NASDAQ:FTH) with a Buy and lowers the price target from $70 to $69.
11-04 22:56
Faeth Therapeutics Q3 EPS $(0.79) Misses $(0.71) Estimate
Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(0.79) per share which missed the analyst consensus estimate of $(0.71) by 11.27 percent. This is a 78.18 percent increase over losses of $(3.62) per share from the same period last year.
11-03 20:33
美股大行评级 | 潜在涨幅94.81%！富瑞上调ArriVent BioPharma(AVBP)目标价至30美元，维持"买入"评级
今日重点评级关注：富瑞：维持ArriVent BioPharma"买入"评级，目标价从18美元升至30美元；古根海姆：维持第一太阳能"买入"评级，目标价从282美元升至299美元
10-28 12:30
BTIG Reiterates Buy on Faeth Therapeutics, Maintains $55 Price Target
BTIG analyst Jeet Mukherjee reiterates Faeth Therapeutics (NASDAQ:FTH) with a Buy and maintains $55 price target.
10-27 17:47
William Blair Initiates Coverage On Faeth Therapeutics with Outperform Rating
William Blair analyst Alethia Young initiates coverage on Faeth Therapeutics (NASDAQ:FTH) with a Outperform rating.
10-16 22:31
Small-cap stocks with strong momentum grades and triple-digit YTD gains
A group of U.S. small-cap stocks is flashing A+ momentum grades in the latest quantitative screen, with several names posting triple-digit gains year to date. Seeking Alpha's Quant Momentum Grade meas...
09-17 21:55
美股大行评级 | 矿业股获齐声唱多！金田、纽曼矿业等目标价均获上调；携程遭看淡至60美元，较现价仍溢价5成
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从10.25美元升至11美元；Needham：上调Rocket Pharmaceuticals"买入"评级，目标价9美元
09-17 16:16
